| Item | Current | Prior | YoY % |
|---|---|---|---|
| Net Sales | ¥186.56B | ¥176.54B | +5.7% |
| Cost of Sales | ¥124.91B | ¥117.79B | +6.0% |
| Gross Profit | ¥61.64B | ¥58.74B | +4.9% |
| SG&A Expenses | ¥53.86B | ¥48.21B | +11.7% |
| Operating Income | ¥7.79B | ¥10.53B | -26.1% |
| Non-operating Income | ¥1.20B | ¥1.31B | -8.0% |
| Non-operating Expenses | ¥1.60B | ¥672M | +138.2% |
| Ordinary Income | ¥7.39B | ¥11.17B | -33.9% |
| Profit Before Tax | ¥8.58B | ¥13.72B | -37.5% |
| Income Tax Expense | ¥5.29B | ¥4.02B | +31.7% |
| Net Income | ¥3.29B | ¥9.70B | -66.1% |
| Net Income Attributable to Owners | ¥5.70B | ¥9.09B | -37.3% |
| Total Comprehensive Income | ¥-3.50B | ¥22.48B | -115.6% |
| Depreciation & Amortization | ¥5.95B | ¥5.00B | +19.1% |
| Interest Expense | ¥707M | ¥311M | +127.3% |
| Basic EPS | ¥29.40 | ¥46.55 | -36.8% |
| Dividend Per Share | ¥31.00 | ¥31.00 | +0.0% |
| Item | Current End | Prior End | Change |
|---|---|---|---|
| Current Assets | ¥224.18B | ¥245.43B | ¥-21.25B |
| Cash and Deposits | ¥60.56B | ¥83.30B | ¥-22.74B |
| Accounts Receivable | ¥71.94B | ¥73.32B | ¥-1.38B |
| Inventories | ¥73.89B | ¥72.80B | +¥1.10B |
| Non-current Assets | ¥252.43B | ¥232.15B | +¥20.27B |
| Item | Current | Prior | Change |
|---|---|---|---|
| Operating Cash Flow | ¥5.97B | ¥6.21B | ¥-239M |
| Investing Cash Flow | ¥-18.35B | ¥-2.31B | ¥-16.04B |
| Financing Cash Flow | ¥-6.79B | ¥-9.14B | +¥2.34B |
| Free Cash Flow | ¥-12.38B | - | - |
| Item | Value |
|---|---|
| Net Profit Margin | 3.1% |
| Gross Profit Margin | 33.0% |
| Current Ratio | 331.6% |
| Quick Ratio | 222.3% |
| Debt-to-Equity Ratio | 0.66x |
| Interest Coverage Ratio | 11.01x |
| EBITDA Margin | 7.4% |
| Effective Tax Rate | 61.7% |
| Item | YoY Change |
|---|---|
| Net Sales YoY Change | +5.7% |
| Operating Income YoY Change | -26.1% |
| Ordinary Income YoY Change | -33.9% |
| Net Income Attributable to Owners YoY Change | -37.3% |
| Total Comprehensive Income YoY Change | -14.4% |
| Item | Value |
|---|---|
| Shares Outstanding (incl. Treasury) | 197.25M shares |
| Treasury Stock | 4.38M shares |
| Average Shares Outstanding | 193.68M shares |
| Book Value Per Share | ¥1,490.38 |
| EBITDA | ¥13.74B |
| Item | Amount |
|---|---|
| Year-End Dividend | ¥31.00 |
| Segment | Revenue | Operating Income |
|---|---|---|
| TakaraBioGroup | ¥103.89B | ¥6.66B |
| TakaraHealthcare | ¥18.79B | ¥-2.34B |
| TakaraShuzoGroup | ¥57.76B | ¥2.46B |
| Item | Forecast |
|---|---|
| Net Sales Forecast | ¥392.00B |
| Operating Income Forecast | ¥16.20B |
| Ordinary Income Forecast | ¥15.70B |
| Net Income Attributable to Owners Forecast | ¥11.10B |
| Basic EPS Forecast | ¥57.43 |
| Dividend Per Share Forecast | ¥31.00 |
| Property, Plant & Equipment | ¥128.93B | ¥123.61B | +¥5.32B |
| Intangible Assets | ¥57.77B | ¥41.66B | +¥16.11B |
| Goodwill | ¥30.10B | ¥25.28B | +¥4.81B |
| Investment Securities | ¥35.65B | ¥34.47B | +¥1.18B |
| Total Assets | ¥476.61B | ¥477.59B | ¥-976M |
| Current Liabilities | ¥67.62B | ¥73.42B | ¥-5.80B |
| Accounts Payable | ¥23.84B | ¥24.07B | ¥-226M |
| Short-term Loans | ¥6.35B | ¥12.31B | ¥-5.97B |
| Non-current Liabilities | ¥121.54B | ¥103.26B | +¥18.27B |
| Long-term Loans | ¥40.52B | ¥30.69B | +¥9.84B |
| Total Liabilities | ¥189.15B | ¥176.68B | +¥12.47B |
| Total Equity | ¥287.46B | ¥300.90B | ¥-13.45B |
| Capital Stock | ¥13.23B | ¥13.23B | ¥0 |
| Capital Surplus | ¥2.80B | ¥2.80B | ¥0 |
| Retained Earnings | ¥180.09B | ¥180.45B | ¥-357M |
| Treasury Stock | ¥-5.10B | ¥-2.10B | ¥-3.00B |
| Owners' Equity | ¥237.22B | ¥245.23B | ¥-8.00B |
| Working Capital | ¥156.57B | - | - |